In Brief: Correction
This article was originally published in The Gray Sheet
Correction: ProCyte is actively seeking corporate partners to market its Iamin gel in hospital and home wound care markets in North America but has not identified any specific firms. The "The Gray Sheet" (Aug. 25, I&W-6) incorrectly reported ProCyte was negotiating with one of three potential partners...
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.